Wednesday, March 16, 2016

BRIEF-Halozyme doses first patient in phase 3 clinical trial of PEGPH20 in combination with ABRAXANE and Gemcitabine

* Halozyme doses first patient in phase 3 clinical trial of

pegph20 in combination with abraxane and gemcitabine

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)